DrKW boosts credit and derivatives sales and marketing

Scott Nichols has joined DrKW as a director for sales and marketing, responsible for the distribution of credit products in the Nordic region. Nichols previously worked at Svenska Handelsbanken in Stockholm, where he was a manager for bond syndicate and credit products. Nichols will report to Giovanni Marolda, DrKW’s European head of credit sales.

The German bank hired Jan Sass Kindberg as a director responsible for the marketing of liquid market products to clients in the Nordic region. Kindberg was hired from HypoVereinsbank, where he was a senior sales manager for the Nordic region. Kindberg will report to Charles Matterson, DrKW's head of liquid market sales for Europe.

Alex Grobman has also joined DrKW as a director responsible for marketing credit products to hedge funds. Grobman was hired from Commerzbank where he marketed convertible bonds to European and American based hedge funds. At DrKW, Grobman will reports to Angela Osborne, head of hedge Fund sales, and Marolda. Meanwhile, Mike Egerton was hired as a director of derivatives marketing, covering financial institutions in the UK and Ireland. Prior to joining DrKW, Egerton marketed structured products to clients at Deutsche Bank and Merrill Lynch.

And DrKW has recruited Albert Shamash as a vice-president of derivatives marketing, covering life insurance companies in the UK. Shamash joins from Swiss Re where he worked for five years and qualified as a UK life actuary.

Both Egerton and Shamash will report to John Cusins, co-head financial institutions derivatives marketing.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here